Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Robert Silverman, PhD

216.445.9650

Robert Silverman, Ph.D.

Appointed: 1991

Robert Silverman, PhD
Department: Cancer Biology
Location: Cleveland Clinic Main Campus
Mail Code NB40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.9650
WorkFax:216.445.6269
Robert Silverman, PhD
Department: Taussig Cancer Institute
Location: Cleveland Clinic Main Campus
Mail Code NB40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.9650
WorkFax:216.445.6269
Surgeon:
No
Treats:
Adults Only

Education & Fellowships

Doctorate - Iowa State University
Ames, IA USA
1977
Undergraduate - Michigan State University
East Lansing, MI USA
1970
Fellowship - Roche Institute of Molecular Biology
NJ USA
Fellowship - National Institute for Medical Research

Fellowship - Imperial Cancer Research Fund
London United Kingdom

Specialty Interests

Prostate cancer etiology and genetics, viral pathogenesis

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/27/2014, Dr. Silverman has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Silverman receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • Abcam, plc
  • Alios BioPharma, Inc.
  • EMD Millipore Corporation
  • GlaxoSmithKline plc.
  • Life Technologies Corporation
  • Santa Cruz Biotechnology, Inc.

Equity. Dr. Silverman owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

  • Alios BioPharma, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Silverman may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • Abcam, plc
  • Alios BioPharma, Inc.
  • EMD Millipore Corporation
  • GlaxoSmithKline plc.
  • Life Technologies Corporation
  • Santa Cruz Biotechnology, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English